Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics

Ann Neurol. 2000 Dec;48(6):943-7.

Abstract

Continuous subcutaneous administration of polyamine-modified catalase that has increased permeability at the blood-brain barrier showed both a highly significant delay in onset and an increase in survival in a transgenic mouse model of familial amyotrophic lateral sclerosis having a point mutation in the gene encoding copper/zinc superoxide dismutase. These results suggest that hydrogen peroxide-mediated oxidative stress with subsequent free radical damage involving nitric oxide and possibly hydroxyl radicals in motor neurons may be the culprit in familial amyotrophic lateral sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / genetics
  • Animals
  • Blood-Brain Barrier
  • Catalase / metabolism
  • Catalase / physiology*
  • Hydrogen Peroxide / metabolism*
  • Mice
  • Mice, Transgenic
  • Nitric Oxide / metabolism*
  • Putrescine / analogs & derivatives
  • Putrescine / pharmacology*
  • Survival Analysis

Substances

  • Nitric Oxide
  • Hydrogen Peroxide
  • Catalase
  • Putrescine